Eric Singhi, Thoracic Medical Oncologist and Assistant Professor at MD Anderson Cancer Center, shared a post on LinkedIn:
“New Nature Magazine review led by Dr. Jianjun Zhang MD Anderson Cancer Center: LDCT screening saves lives, but uptake is low (<20% in US) and >50% lung cancers occur outside current criteria.
The Future? Biology-driven precision screening (AI/radiomics, liquid bx, VOCs) + precancer interception (IL-1B, PD-1).”
Title: Innovative approaches for lung cancer screening and interception
Authors: Jianjun Zhang, Matthew D. Park, Tej Pandya, Elaine Shum, Jia Wu, Simon Heeke, Ramin Salehi-Rad, Thomas U. Marron, Zhubo Wei, Hui Li, Torsten G. Blum,
John V. Heymach, Steven M. Dubinett, Pan-Chyr Yang, Charles Swanton and Miriam Merad.
Other articles featuring Eric Singhi on OncoDaily.